Gemcitabine News and Research

RSS
Gemcitabine is the active ingredient in a drug that is used to treat pancreatic cancer that is advanced or has spread. It is also used together with other drugs to treat breast cancer that has spread, advanced ovarian cancer, and non-small cell lung cancer that is advanced or has spread. It is also being studied in the treatment of other types of cancer. Gemcitabine blocks the cell from making DNA and may kill cancer cells. It is a type of antimetabolite
Researchers design new medicine to treat highly aggressive pancreatic cancer

Researchers design new medicine to treat highly aggressive pancreatic cancer

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

Trial shows PARP inhibitor as novel treatment option for patients with advanced breast cancers

Trial shows PARP inhibitor as novel treatment option for patients with advanced breast cancers

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

AntiCancer's oral drug overcomes gemcitabine resistance in mouse models of human pancreatic cancer

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Genentech researchers uncover epigenetic regulator of pancreatic cancer cells

Genentech researchers uncover epigenetic regulator of pancreatic cancer cells

PARP inhibitor can be new treatment option for patients with metastatic breast cancer, BRCA mutations

PARP inhibitor can be new treatment option for patients with metastatic breast cancer, BRCA mutations

New research can help develop better chemotherapy treatments for pancreatic cancer

New research can help develop better chemotherapy treatments for pancreatic cancer

Research shows how bacteria inactivate common drug used to treat cancers

Research shows how bacteria inactivate common drug used to treat cancers

Researchers define how cancer drug works in cells, mice and man

Researchers define how cancer drug works in cells, mice and man

Bone metastasis-targeting drug shows potential as new therapeutic strategy for osteosarcoma

Bone metastasis-targeting drug shows potential as new therapeutic strategy for osteosarcoma

Combination therapy has complete response rate in children, young adults with Hodgkin lymphoma

Combination therapy has complete response rate in children, young adults with Hodgkin lymphoma

Researchers explore new treatment combination for pediatric patients with Hodgkin lymphoma

Researchers explore new treatment combination for pediatric patients with Hodgkin lymphoma

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Scientists identify vulnerabilities of highly aggressive pancreatic cancer cells

Scientists identify vulnerabilities of highly aggressive pancreatic cancer cells

Antivirals that block influenza can also inhibit Zika virus infection, study shows

Antivirals that block influenza can also inhibit Zika virus infection, study shows

New treatment can halt growth of liver cancer cells, research shows

New treatment can halt growth of liver cancer cells, research shows

Super-resolution imaging of biological specimens: an interview with Dr. Manasa Gudheti

Super-resolution imaging of biological specimens: an interview with Dr. Manasa Gudheti